General Announcement::Notice of 41st Annual General Meeting of the Company for FY 2018-19

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
03-Sep-2019 22:05:52
Status
New
Announcement Sub Title
Notice of 41st Annual General Meeting of the Company for FY 2018-19
Announcement Reference
SG190903OTHRABCI
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Ltd.
Designation
Company Secretary & Compliance Officer
Description (Please provide a detailed description of the event in the box below)
Notice of 41st Annual General Meeting of the Company for FY 2018-19

Attachments

Glenmark_AGM_Notice_2019_SGX_03092019.pdf
Total size =1408K